Capsulution NanoScience AG Diagnostic Particle Expert Appointed to Advisory Board
Berlin (March 22, 2004) - Since February this year Harri Härmä, PhD, scientist at the Department of Biotechnology at the University of Turku, Finland, is the most recent member appointed to the scientific advisory board of the Berlin-based technology company Capsulution NanoScience AG.

37-year old Härmä is a renowned expert in the field of diagnostic particles, and has substantially contributed to several industry reports on this subject. In addition to this he is co-author of numerous publications. His research activities are in the fields of nanoparticles, fluorescent dyes, nanoparticle-based assays as well as innovative homogeneous and heterogeneous assay methods.

During the 90s Härmä worked for the Finnish chemical companies Kemira Ltd and Leiras Ltd, for the Swiss chemical corporation Ciba-Geigy as well as for the University of Zurich. Currently, he acts as a senior scientist in the University of Turku, where he is involved in different research projects.

Härmä extends Capsulution.s scientific advisory board on which Prof. Dieter Berg (Bayer AG, D), Prof. Helmuth Möhwald (Max-Planck-Institute for Colloids and Interfaces, D), Prof. Clive Wilson (Strathclyde Institute for Biomedical Sciences, UK) and Prof. Achim Göpferich (University of Regensburg, D) already hold positions.

Alexander Herrmann, CFO of Capsulution commented on Härmä's appointment: "We are very pleased to have won Harri Härmä for our already highly profiled advisory board. His many year.s experience and knowledge in the research field of particle technologies will be a valuable contribution to the recently started extension of Capsulution.s business activities to the application of our multifunctional beads (capsules) to the lucrative diagnostic market."

251 words / 1,721 charcters

Capsulution NanoScience AG:
Capsulution NanoScience AG develops innovative nano- and micron-sized capsules. The company applies its proprietary so-called LBL-Technology®. Based on their minute size, their functionality and their highly reproducible production process the capsules can be used for a multitude of different applications. Accordingly, the precisely sized capsules (500 nm to 50 µm) can be made to function in a manner to suit the intended application, and can be given the appropriate biochemical, electrical, optical and magnetic properties as required by the customer. The capsules can be applied for the delivery of drugs, in cosmetic products, and in diagnostics. Today, the Berlin-based company has 16 highly qualified employees. Amongst Capsulution's clients and partners are key industrial players such as Bayer AG, Gelita, SCA Hygiene Products, Cognis, OctoPlus and other renowned companies.

Downloads: Text as RTF file in the "Press Pool" at www.biocommunications.net 

Contact:
Capsulution NanoScience AG
Alexander Herrmann (CFO)
Volmerstr. 7b
D-12489 Berlin, Germany
Tel.: +49-30-6392-3627
Fax.: +49-30-6392-3601
www.capsulution.com 
Email: alexander.herrmann@capsulution.com 

© BIOCOMMUNICATIONS.net GmbH, Berlin - Reprint free of charge. Please supply copy.